Gene expression profiles of two accelerations in a CML patient

Leuk Res. 2006 Jun;30(6):751-3. doi: 10.1016/j.leukres.2005.10.008. Epub 2005 Nov 14.

Authors

Karel Fiser¹, Hana Klamová, Jana Moravcová

Affiliation

¹ Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, U Nemocnice 1, 12820 Prague, Czech Republic. Karel.Fiser@uhkt.cz

PMID: 16289682
DOI: 10.1016/j.leukres.2005.10.008

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Blast Crisis / drug therapy
Blast Crisis / genetics*
Blast Crisis / pathology
Cytarabine / administration & dosage
Gene Expression Profiling / methods
Gene Expression Regulation, Leukemic* / drug effects
Granulocyte Colony-Stimulating Factor / administration & dosage
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Male
Mitoxantrone / administration & dosage
Multigene Family / genetics*
Oligonucleotide Array Sequence Analysis / methods
Vidarabine / administration & dosage
Vidarabine / analogs & derivatives

Substances

Cytarabine
Granulocyte Colony-Stimulating Factor
Mitoxantrone
Vidarabine

Supplementary concepts

FLAG protocol
FLAM regimen